Palantir's stock has more than doubled in 2025 -- here's why the upcoming earnings could decide whether it soars even higher or hits turbulence.

Palantir's Q2 2025 earnings are expected to impress with 39% YoY revenue growth, but lofty valuations pose risks.

Palantir Technologies Inc. (NYSE: PLTR) has been on a roll in 2025. Up 100% in 2025, it is one of the best performing stocks ...

Palantir has pushed its way into the top tier of American corporations, crossing a major line with a market cap of $375 billion after a 2% jump in its share ...

Polymarket exploded into the public eye during the 2024 election between President Donald Trump and President Joe Biden.

Nobody will catch every idea, but long-time Wall Street analyst Stephen Guilfoyle is on a bit of a winning streak. He was ...

Needham initiated coverage on Shopify ( NASDAQ: SHOP) with a Buy rating as the firm believes the company remains in only the mid-cycle of a durable growth opportunity, with significant recent ...

NE 42nd Avenue Bridge in Portland to close for two years starting August 4, impacting traffic and local businesses.

The conference call is scheduled to begin at 8:00 a.m. ET on Monday, August 4, 2025. To participate on the live call, listeners in North America may dial (877) 407-0792 and international listeners ...

6 Arts Notes The Elephant Man auditions to be held August 3, 4, 5 July 15, 2025 by The Spy Desk Leave a Comment Many know the story of Bernard Pomerance’s play “The Elephant Man.” In 1880s London, ...

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that it will issue its financial ...

Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025 ...